Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EBZ
|
|||
| Former ID |
DNC000737
|
|||
| Drug Name |
HMR1883
|
|||
| Synonyms |
Clamikalant; Clamikalant [INN]; 158751-64-5; UNII-94301K998R; CHEMBL12531; HMR-1883; 94301K998R; 1-((5-(2-(5-Chloro-o-anisamido)ethyl)-2-methoxyphenyl)sulfonyl)-3-methyl-2-thiourea; HMR1883; AC1MI3H0; SCHEMBL726268; DTXSID30166522; VXTKXGKPBOLHRY-UHFFFAOYSA-N; ZINC599915; BDBM50099573; AKOS027339538; API0011065; NCGC00386636-01; AS-44931; LS-26123; SR-01000945051; SR-01000945051-1; 5-chloro-2-methoxy-N-[2-[4-methoxy-3-(methylcarbamothioylsulfamoyl)phenyl]ethyl]benzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22ClN3O5S2
|
|||
| Canonical SMILES |
CNC(=S)NS(=O)(=O)C1=C(C=CC(=C1)CCNC(=O)C2=C(C=CC(=C2)Cl)OC)OC
|
|||
| InChI |
1S/C19H22ClN3O5S2/c1-21-19(29)23-30(25,26)17-10-12(4-6-16(17)28-3)8-9-22-18(24)14-11-13(20)5-7-15(14)27-2/h4-7,10-11H,8-9H2,1-3H3,(H,22,24)(H2,21,23,29)
|
|||
| InChIKey |
VXTKXGKPBOLHRY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 158751-64-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Potassium channel unspecific (KC) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clamikalant (Aventis). IDrugs. 2000 Nov;3(11):1353-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.